Agenus INC (AGEN) — 10-Q Filings

All 10-Q filings from Agenus INC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Agenus Swings to Profit on MiNK Deconsolidation, Cash Remains Tight — Nov 10, 2025 Risk: high
Agenus Inc. reported a significant turnaround in net income, achieving $7.5 million for the nine months ended September 30, 2025, compared to a net loss of $185
AGENUS Revenue Jumps 62% on R&D Boost, Net Loss Narrows — Aug 11, 2025 Risk: high
AGENUS INC reported a significant increase in total revenue for the six months ended June 30, 2025, reaching $60.0 million, up from $37.0 million in the prior y
Agenus Inc. Q1 2025 Update: Ligand Deal & Sales Agreements — May 12, 2025 Risk: medium
Agenus Inc. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing indicates various financial activities and agreem
Agenus Inc. Files Q3 2024 10-Q with Financial Details — Nov 12, 2024 Risk: medium
Agenus Inc. reported its third-quarter results for the period ending September 30, 2024. The company's filing details various financial components, including co
Agenus Inc. Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
Agenus Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key fin
Agenus Inc. Files 10-Q for Period Ending March 31, 2024 — May 7, 2024 Risk: medium
AGENUS INC (AGEN) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Agenus Inc. filed a 10-Q report for the quarterly period ended March 31, 2024. Th

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX